Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02272140 · ClinicalTrials.gov registry record
Advanced XLIF Monitoring Multicenter Study
A clinical trial of Degenerative Lumbar Disc Disease, sponsored by NuVasive.
- Completed
- Registry status
- 324
- Enrollment target
- 12
- Study locations
NCT02272140 is a study of Degenerative Lumbar Disc Disease that has completed, run by NuVasive. The registered enrollment target is 324 participants. The trial reports 12 study locations across 10 states.
The verdict
NCT02272140, a study of Degenerative Lumbar Disc Disease, has completed, sponsored by NuVasive.
- COMPLETED
- Registry status
- 324 participants
- Enrollment target
- 12
- Study locations
Study Summary
The objective of this study is to evaluate the utility of localized stimulation of the lumbosacral nerve roots during XLIF through correlation of observed changes in the response latency, amplitude, waveform morphology, and/or response threshold with surgical events. Additionally, correlation between neuromonitoring findings and postoperative neural status will be evaluated.
Conditions Studied
Study Locations (12)
Florida
- USF Neurology and Neurosurgery - Tampa
- Foundation for Orthopaedic Research and Education (FORE) - Tampa
Georgia
- Piedmont Healthcare - Atlanta
- West Augusta Spine Specialists, LLC - Augusta
California
- Scripps Clinical Research Services - La Jolla
Massachusetts
- Massachusetts General Hospital - Boston
Missouri
- Columbia Orthopedic Group Research - Columbia
Nevada
- Western Regional Center for Brain & Spine Surgery - Las Vegas
North Carolina
- Duke University Medical Center - Durham
Pennsylvania
- University of Pittsburgh Medical Center - Pittsburgh
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 324 participants |
| Start Date | 2014-07-09 |
| Est. Completion | 2017-10 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02272140
The ClinicalTrials.gov registry entry for NCT02272140 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 324 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is NuVasive, which has 28 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Degenerative Lumbar Disc Disease appearing as the primary indexed condition, and to 0 interventions.
NCT02272140 reports 12 study locations spanning 10 distinct geographic areas - top geographies include Florida, Georgia, California.
Frequently Asked Questions
What is clinical trial NCT02272140 about?
NCT02272140 is a clinical study titled "Advanced XLIF Monitoring Multicenter Study". The objective of this study is to evaluate the utility of localized stimulation of the lumbosacral nerve roots during XLIF through correlation of observed changes in the response latency, amplitude, waveform morphology, and/or response threshold with surgical events. Additionally, correlation betwee...
What is the current status of trial NCT02272140?
This trial is currently completed. The enrollment target is 324 participants. The study started on 2014-07-09. Estimated completion is 2017-10.
What conditions does trial NCT02272140 study?
This clinical trial studies the following conditions: Degenerative Lumbar Disc Disease.
Who is sponsoring clinical trial NCT02272140?
This trial is sponsored by NuVasive, which has 28 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02272140 being conducted?
This trial has 12 study locations across California, Florida, Georgia, Massachusetts, Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Degenerative Lumbar Disc Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.